$GL

GLOBE LIFE INC. (GL): Results of Operations and Financial Condition

GLOBE LIFE INC. (GL) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q2fy2026earningsrelease.htm EX-99.1 Document GLOBE LIFE INC. REPORTS Second Quarter 2026 Results McKinney, TX, July 22, 2026 —Globe Life Inc. (NYSE: GL) reported today that for the quarter ended June 30, 2026, net income was $3.65 per diluted common share, compared with

Original reporting
Published Jul 22, 2026, 8:34 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 22, 2026, 8:35 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$GL
Bullish
high confidence
Mentioned
$GL
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$GLBullishMed
01

Why it matters

Q2 per-share profitability improved year over year, and management increased FY guidance, which can drive estimate revisions and near-term positioning for GL.

02

Market read

Traders can update GL’s earnings model using the reported Q2 EPS and the raised FY guidance range, which is a direct catalyst for re-rating.

03

What to watch

The release emphasizes non-GAAP net operating income and ROE excluding AOCI; traders should check sensitivity to interest-rate-driven AOCI and any realized investment gains/losses volatility versus prior quarters.

Relevance 7/10Novelty 8/10Timing: after-hours/filing today on SEC 8-K for Q2 2026 results and updated FY guidance

Background

This SEC 8-K includes Globe Life’s Q2 2026 results and an updated full-year 2026 earnings guidance range.

Company-level read

Ticker impact

$GLBullishHigh confidence
Context

Globe Life reported Q2 2026 net income of $3.65 per diluted share and raised full-year 2026 earnings guidance to $15.55 to $15.95.

Expected impact

Likely positive bias for GL on earnings-day positioning, with follow-through dependent on how the market interprets underwriting margin and premium growth sustainability.

Evidence & confidence

This is a primary-source 8-K earnings release with explicit EPS results and a specific full-year guidance range change, which are direct inputs to valuation and estimates.

Market effects

Reinforces the life insurer narrative of steady underwriting margin expansion and premium growth, potentially supporting sentiment toward the group.

No specific regional spillover beyond US life insurance demand and capital markets conditions.

Limited direct global impact; primarily affects US listed life insurers and their estimate baselines.

Counterpoint

The guidance midpoint rises only $0.10, so the market may focus on whether underwriting margin gains are durable rather than the headline EPS beat.

Key entities

  • Globe Life Inc.

    NYSE-listed life and health insurer reporting Q2 2026 results and raising FY 2026 earnings guidance.

Related articles

$GLMedAI 8/10

Globe Life Boosts EPS Outlook Following Strong Q2 Earnings

Globe Life Inc. reported Q2 net income of $288 million, or $3.65 per share, up 20% year over year, and net operating income of $285 million, or $3.61 per share, up 10%. The insurer cited underwriting strength and excess investment returns and raised full-year guidance to 2026 net operating EPS of $15.55-$15.95 and share repurchases of $670M-$700M.

$GLMed

Why Globe Life (GL) Shares Are Sliding Today

Globe Life (NYSE: GL) shares fell about 7% after its Q2 results met Wall Street estimates but did not provide upside. Revenue rose 6.7% to about $1.6B and net premiums earned were about $1.30B. GAAP EPS was $3.65 vs $3.64 expected. The stock closed at $170.96.

$GLMedAI 8/10

Full Transcript: Globe Life Q2 2026 Earnings Call - Globe Life (NYSE:GL)

Globe Life Inc. (NYSE:GL) reported Q2 2026 net income of $288 million, or $3.65 per share, up 20% year over year, and net operating income of $285 million, or $3.61 per share, up 10%. Premium revenue rose 7% (life +3%, health +16%). The company repurchased $175 million of shares and guided full-year net operating EPS growth of 8.5%.

$GLMedAI 8/10

Globe Life Q2 Earnings Call Highlights

Globe Life (NYSE:GL) reported Q2 health premium revenue up 16% to $437M and health underwriting margin up 1% to $99M, though the margin fell to about 23%. Life policy obligations improved. Management raised 2026 net operating EPS guidance to $15.55 to $15.95 and increased buybacks. The company repurchased ~1.1M shares for $175M in Q2.

$GLMedAI 8/10

Why is Globe Life stock sliding today? By Investing.com

Globe Life shares fell 8.1% after its Q2 2026 results. Net operating income was $3.61 per diluted share versus $3.67 consensus, while revenue was $1.60B versus $1.59B. Full-year 2026 EPS guidance was raised to $15.55-$15.95 but the midpoint ($15.75) stayed below $15.65 consensus, alongside insider net selling and a risk-off market.

$GLMedAI 8/10

GLOBE LIFE INC. REPORTS SECOND QUARTER 2026 RESULTS

Globe Life Inc. (NYSE: GL) reported Q2 2026 results for the quarter ended June 30, 2026. Net income was $3.65 per diluted share versus $3.05 a year ago. Full-year 2026 earnings guidance was raised to $15.55 to $15.95. Premium revenue rose 7% and the company repurchased 1.1 million shares for $175 million.